Lu Wang

4.7k citations

141 papers · 3.0k indexed · 2 hit papers · h-index 30

Impact in

Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
Biological Psychiatry top 5%

Papers in ⓘ

Cancer Research 32
- MicroRNA in disease regulation 14
- Cancer, Hypoxia, and Metabolism 9
- Cancer-related molecular mechanisms research 6
Immunology 27
- interferon and immune responses 7
- Immune cells in cancer 6

Co-authors: Hao Zhang (13 shared papers)Hui‐Chuan Sun (7 shared papers)Wei‐Zhong Wu (4 shared papers)Zhao–You Tang (3 shared papers)Xiao Xiong (9 shared papers)Xiao‐Dong Zhu (2 shared papers)Huaxiang Xu (2 shared papers)Ling–Qun Kong (2 shared papers)
Journals: Cancer Letters (3 papers)Clinical Cancer Research (3 papers)Ecological Indicators (2 papers)Cancer Gene Therapy (2 papers)BMC Cancer (2 papers)
Partner nations: China United States Netherlands

In The Last Decade

Lu Wang

131 papers receiving 3.0k citations

Hit Papers

align trajectories log scale

Gut dysbiosis induces the development of depression-like behavior through abnormal synapse pruning in microglia-mediated by complement C3 2024 · 56 citations

Peers

Countries citing papers authored by Lu Wang

Since Specialization

Citations

This map shows the geographic impact of Lu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Wang more than expected).

Fields of papers citing papers by Lu Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Wang. The network helps show where Lu Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Lu Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lu Wang Line = papers co-authored together Lu Wang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 141 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects Clinical Cancer Research ·Wei Zhang, Xiao‐Dong Zhu, Hui‐Chuan Sun, Yuquan Xiong, Peng–Yuan Zhuang, Huaxiang Xu, Ling–Qun Kong, Lu Wang, Wei‐Zhong Wu, Zhao–You Tang	2010	330
2	Metformin induces human esophageal carcinoma cell pyroptosis by targeting the miR-497/PELP1 axis Cancer Letters ·Lu Wang, Kai Li, Xianjie Lin, Zhimeng Yao, Shuhong Wang, Xiao Xiong, Zhifeng Ning, Jing Wang, Xiaozheng Xu, Yi Jiang, Ditian Liu, Yuping Chen, Dianzheng Zhang, Hao Zhang	2019	188
3	A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter prospective study Molecular Cancer ·Kai Li, Yusheng Lin, Yichen Luo, Xiao Xiong, Lu Wang, Kameron Durante, Junkuo Li, Fuyou Zhou, Yi Guo, Shaobin Chen, Yuping Chen, Dianzheng Zhang, Sai‐Ching J. Yeung, Hao Zhang Hit paper breakdown →	2022	145
4	Co‐Delivery of Doxorubicin and siRNA with Reduction and pH Dually Sensitive Nanocarrier for Synergistic Cancer Therapy Small ·Weicai Chen, Yuanyuan Yuan, Du Cheng, Jifeng Chen, Lu Wang, Xintao Shuai	2014	143
5	Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial Clinical Cancer Research ·Shuhong Wang, Yusheng Lin, Xiao Xiong, Lu Wang, Yi Guo, Yuping Chen, Shaobin Chen, Geng Wang, Lin Peng, Hongcai Chen, Sai‐Ching J. Yeung, Edwin Bremer, Hao Zhang	2020	119
6	Prevalence of coal workers’ pneumoconiosis in China: A systematic analysis of 2001–2011 studies International Journal of Hygiene and Environmental Health ·Jing-fu Mo, Lu Wang, William W. Au, Min Su	2013	84
7	HIWI is associated with prognosis in patients with hepatocellular carcinoma after curative resection Cancer ·Yiming Zhao, Jia‐Min Zhou, Long‐Rong Wang, Long‐Rong Wang, Hongwei He, Xilong Wang, Zhonghua Tao, Hui‐Chuan Sun, Wei‐Zhong Wu, Jia Fan, Zhao–You Tang, Lu Wang	2011	79
8	Overexpression of Platelet-Derived Growth Factor Receptor α in Endothelial Cells of Hepatocellular Carcinoma Associated with High Metastatic Potential Clinical Cancer Research ·Ti Zhang, Hui‐Chuan Sun, Yang Xu, Kezhi Zhang, Lu Wang, Lun–Xiu Qin, Wei‐Zhong Wu, Yinkun Liu, Sheng‐Long Ye, Zhao–You Tang	2005	72
9	Discovery of Novel Potent VEGFR-2 Inhibitors Exerting Significant Antiproliferative Activity against Cancer Cell Lines Journal of Medicinal Chemistry ·Yanmin Zhang, Yadong Chen, Danfeng Zhang, Lu Wang, Tao Lu, Yu Jiao	2017	72
10	Effects of oxymatrine on proliferation and apoptosis in human hepatoma cells Colloids and Surfaces B Biointerfaces ·Guanbin Song, Qing Luo, Jian Qin, Lu Wang, Yisong Shi, Caixin Sun	2006	71
11	In vitro and in vivo anti-inflammatory effects of theaflavin-3,3′-digallate on lipopolysaccharide-induced inflammation European Journal of Pharmacology ·Yanting Wu, Fujun Jin, Yiliang Wang, Li Feng, Lu Wang, Qiao-Li Wang, Zhe Ren, Yifei Wang	2016	63
12	Cytochrome P450 3A Induction Predicts P‐glycoprotein Induction; Part 1: Establishing Induction Relationships Using Ascending Dose Rifampin Clinical Pharmacology & Therapeutics ·Justin D. Lutz, Brian J. Kirby, Lu Wang, Qinghua Song, John Ling, Benedetta Massetto, Angela Worth, Brian P. Kearney, Anita Mathias	2018	63
13	Plant cyclopeptide RA-V kills human breast cancer cells by inducing mitochondria-mediated apoptosis through blocking PDK1–AKT interaction Toxicology and Applied Pharmacology ·Xianying Fang, Wei Chen, Jun-Ting Fan, Ran Song, Lu Wang, Yan-Hong Gu, Guang‐Zhi Zeng, Yan Shen, Xue-Feng Wu, Ning-Hua Tan, Qiang Xu, Yang Sun	2012	59
14	Diagnostic and prognostic value of plasma microRNA deregulation in nasopharyngeal carcinoma Cancer Biology & Therapy ·Xiong Liu, Hua-Nan Luo, Wen-Dong Tian, Juan Lü, Gang Li, Lu Wang, Zhang Bao, Bi-Jun Liang, Xiao-Hong Peng, Shao-Xiong Lin, Ying Peng, Xiang-Ping Li	2013	59
15	NLRP3 Activation Was Regulated by DNA Methylation Modification duringMycobacterium tuberculosisInfection BioMed Research International ·Meili Wei, Lu Wang, Tao Wu, Jun Xi, Yu-Ze Han, Xingxiang Yang, Ding Zhang, Qiang Fang, Bikui Tang	2016	56
16	Gut dysbiosis induces the development of depression-like behavior through abnormal synapse pruning in microglia-mediated by complement C3 Microbiome ·Wenzhi Hao, Qingyu Ma, Lu Wang, Naijun Yuan, Hua Gan, Liangliang He, Xiaojuan Li, Junqing Huang, Jiaxu Chen Hit paper breakdown →	2024	56
17	Octreotide acts as an antitumor angiogenesis compound and suppresses tumor growth in nude mice bearing human hepatocellular carcinoma xenografts Journal of Cancer Research and Clinical Oncology ·Jian Wang, Jiansheng Li, Zhi-Ming Zhai, Qiong Xue, Weidong Jia, Ge‐Liang Xu, Rong-Nan Xu, Hui‐Chuan Sun, Lu Wang, Ji-Hai Yu	2003	49
18	RNA activation: Promise as a new weapon against cancer Cancer Letters ·Zheng Lin, Lu Wang, Jinfeng Gan, Hao Zhang	2014	42
19	MCC950, a NLRP3 inhibitor, ameliorates lipopolysaccharide-induced lung inflammation in mice Bioorganic & Medicinal Chemistry ·Lu Wang, Lei Wu, Shui-juan Zhang, Yao Li	2020	41
20	Salivary Extracellular MicroRNAs for Early Detection and Prognostication of Esophageal Cancer: A Clinical Study Gastroenterology ·Kai Li, Yusheng Lin, Yu Zhou, Xiao Xiong, Lu Wang, Junkuo Li, Fuyou Zhou, Yi Guo, Shaobin Chen, Yuping Chen, Hui Tang, Xiaofu Qiu, Songwang Cai, Dianzheng Zhang, Edwin Bremer, Sai‐Ching J. Yeung, Hao Zhang	2023	40

About Lu Wang

Lu Wang is a scholar working on Cancer Research, Immunology, Biological Psychiatry, Molecular Biology and Oncology, having authored 141 papers that have together received 3.0k indexed citations. Recurring topics across this work include Inflammasome and immune disorders (19 papers), MicroRNA in disease regulation (14 papers), Cancer Immunotherapy and Biomarkers (9 papers), Cancer, Hypoxia, and Metabolism (9 papers), interferon and immune responses (7 papers), Immune cells in cancer (6 papers), Cancer-related molecular mechanisms research (6 papers) and Extracellular vesicles in disease (6 papers). The work is most often cited by research in Cancer Research (683 citations), Biological Psychiatry (75 citations), Immunology (543 citations), Molecular Biology (1.6k citations) and Oncology (615 citations). Lu Wang has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Hao Zhang, Hui‐Chuan Sun, Wei‐Zhong Wu, Zhao–You Tang, Xiao Xiong, Xiao‐Dong Zhu, Huaxiang Xu, Ling–Qun Kong, Peng–Yuan Zhuang and Yuquan Xiong. Their work appears in journals such as Cancer Letters, Clinical Cancer Research, Ecological Indicators, Cancer Gene Therapy and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact